この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1994/8/171 分で読めます
Review of Regulations for General Biologics and Licensing and Blood Establishments and Blood Products; Extension of Comment Periods
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is extending to November 15, 1994, the comment periods for two documents. The documents requested comments on FDA's intent to review certain biologics regulations, and were published in the Federal Register of June 3, 1994 (59 FR 28821 and 28822, respectively). FDA is taking this action in response to requests to allow additional time for public comment.
情報源の原言語: Federal Register — Health and Human Services原文の発表を開く →